American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 6(63), 2019
DOI: 10.1128/aac.02673-18
Full text: Unavailable
In vitro pharmacokinetic/pharmacodynamic data of liposomal amphotericin B (L-AMB) were compared with animal data from neutropenic and nonneutropenic models of azole-susceptible and azole-resistant invasive aspergillosis. L-AMB was equally effective.